Drugs Made In America Acquisition Stock (NASDAQ:DMAA)
Previous Close
$10.25
52W Range
$9.95 - $10.27
50D Avg
$10.10
200D Avg
$10.06
Market Cap
$237.21M
Avg Vol (3M)
$83.10K
Beta
-0.01
Div Yield
-
DMAA Company Profile
Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.